Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Bjørn Fehrmann"'
Autor:
Juyoung Hong, Jae-Woong Hwang, Pia Høier, Shinjung Lee, Hyoung Taek Lim, Bjørn Fehrmann, Jinhan Chung, Mourad Farouk Rezk, Niels Hvorslev, Mette Ottosen, Hans C. Ebbers
Publikováno v:
Biodrugs
Background Biosimilars must meet stringent regulatory requirements, both at the time of authorization and during their lifecycle. Yet it has been suggested that divergence in quality attributes over time may lead to clinically meaningful differences